Literature DB >> 7635521

Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.

R Maccario1, P Comoli, E Percivalle, D Montagna, F Locatelli, G Gerna.   

Abstract

Previous studies have demonstrated that herpes simplex virus-1 (HSV-1)-infected mononuclear cells are able to stimulate autologous peripheral blood mononuclear cells (PBMC) of immune donors and to activate HSV-specific cytotoxic T lymphocytes (CTL) expressing either gamma delta or alpha beta T-cell receptors (TCR). In the present report characterization of 10 gamma delta+ and six alpha beta+ HSV-specific cytotoxic T-cell colonies (TCC) is described. Cytotoxic colonies were derived from HSV-induced cell lines of three donors who, in previous experiments, had shown a prevalence of gamma delta+ or alpha beta+ effector cells. HSV-1 induced cell lines obtained from gamma delta responders included more than 80% of cells expressing V gamma 9/delta 2 TCR V region chains. gamma delta+ TCC also expressed V gamma 9/delta 2 molecules. alpha beta+ TCC all expressed CD8 antigen, while only one of 10 gamma delta+ TCC was CD8+, the others being CD4/CD8-double negative. The cytotoxic response of HSV-specific TCC was HLA-unrestricted; nevertheless CD8+ TCC were dependent on the expression of HLA class I on the surface of target cells to mediate cytolytic activity, while CD8- TCC were not. Blocking experiments with monoclonal antibody (mAb) specific for lymphocyte function-associated antigen-1 (LFA-1), which is expressed on all TCC, demonstrated that all alpha beta+ TCC and some gamma delta+ TCC also needed the interaction between LFA-1 and its ligands to develop cytotoxic activity. Altogether our data suggest that HSV-specific CTL may represent a population selected by a high concentration of antigen with a broad range of TCR affinities, which may play an important role as a first line of defence against HSV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635521      PMCID: PMC1384023     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions.

Authors:  D Davignon; E Martz; T Reynolds; K Kürzinger; T A Springer
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

Review 3.  The roles of CD8 in cytotoxic T lymphocyte function.

Authors:  A M O'Rourke; M F Mescher
Journal:  Immunol Today       Date:  1993-04

4.  LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation.

Authors:  A M Krensky; E Robbins; T A Springer; S J Burakoff
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

5.  Characterization of an antigen expressed by human natural killer cells.

Authors:  J D Griffin; T Hercend; R Beveridge; S F Schlossman
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

6.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

7.  Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.

Authors:  K K Sethi; Y Omata; K E Schneweis
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

8.  Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cells.

Authors:  M Lakhdar; A Senik; W H Fridman
Journal:  Cell Immunol       Date:  1984-02       Impact factor: 4.868

9.  Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.

Authors:  H S Larsen; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

View more
  6 in total

1.  Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle.

Authors:  M T Winkler; A Doster; C Jones
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis.

Authors:  R Sciammas; P Kodukula; Q Tang; R L Hendricks; J A Bluestone
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

3.  Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy.

Authors:  Michael A Poles; Shady Barsoum; Wenjie Yu; Jian Yu; Patricia Sun; Jeanine Daly; Tian He; Saurabh Mehandru; Andrew Talal; Martin Markowitz; Arlene Hurley; David Ho; Linqi Zhang
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 4.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

5.  Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.

Authors:  Franck Halary; Vincent Pitard; Dorota Dlubek; Roman Krzysiek; Henri de la Salle; Pierre Merville; Claire Dromer; Dominique Emilie; Jean-François Moreau; Julie Déchanet-Merville
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

Review 6.  Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches.

Authors:  Ailar Sabbaghi; Seyed Mohammad Miri; Mohsen Keshavarz; Mehran Mahooti; Arghavan Zebardast; Amir Ghaemi
Journal:  Virol J       Date:  2020-11-12       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.